Abstract
Aims A substitution effect occurs when patients substitute Medical Cannabis (MC) for another drug. Over three-quarters (76.7%) of New England dispensary members reported reducing their use of opioids and two-fifths (42.0%) decreased their use of alcohol after starting MC (Piper et al. 2017). The objective of this exploratory study was to identify any factors which differentiate alcohol substituters from those that do not modify their alcohol use after starting MC (non-substituters).
Methods Among dispensary patients (N=1,477), over two-thirds with chronic pain, that completed an online survey, 7.4% indicated that they regularly consumed alcohol. Comparisons were made to identify any demographic or health history characteristics which differentiated alcohol substituters (N=47) from non-substituters (N=65). Respondents selected from among a list of 37 diseases and health conditions (e.g. diabetes, sleep disorders) and the total number was calculated.
Results Substituters and non-substituters were indistinguishable in terms of sex, age, or prior drug history. Substituters were significantly more likely to be employed (68.1%) than non-substituters (51.1%). Substituters also reported having significantly more health conditions and diseases (3.3±2.0) than non-substituters (2.4±1.4).
Conclusions This small study offers some insights into the profile of patients whose self-reported alcohol intake decreased following initiation of MC. Alcohol substituters had more other health conditions but also were more likely to be employed which may indicate that they fit a social drinker profile. Additional prospective or controlled research into the alcohol substitution effect following MC with a sample with more advanced alcohol misuse may be warranted.
Short summary A substitution effect with medical cannabis replacing prescription opioids has been reported but less is known for alcohol. This study evaluated characteristics which might differentiate alcohol substituters (N=47) from non-substituters (N=65) among dispensary members. Substituters were significantly more likely to be employed and have more health conditions than non-substituters.
Competing Interest Statement
BJP is supported by the Fahs-Beck Fund for Research & Experimentation and the Health Resources and Services Administration (D34HP31025). AH was supported by the Summer Research Immersion Program. BJP has received research support from the Center for Wellness Leadership, a non-profit organization, and supplies from the National Institute of Drug Abuse (NIDA); travel related to medical marijuana (NIDA, Wellness Connection of Maine, Patients Out of Time, and the Hereditary Neuropathy Foundation). AH has no disclosures.
Funding Statement
No external funding was received specifically for this project.
Author Declarations
All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.
Not Applicable
Footnotes
↵* Department of Medical Education, Geisinger Commonwealth School of Medicine, 525 Pine Streets, Scranton PA 18509, Ph: (413) 347-7199; Fax: (570) 504-9660, Email: bpiper{at}som.geisinger.edu; psy391{at}gmail.com
Data Availability
The online survey is included as a supplemental material. Our IRB approved consent precludes sharing of the raw data.
